Data driven analysis at the intersection of healthcare and economics.

  • Arussa Beyond the Bench aims to unravel the socioeconomic complexities of the healthcare system within the UK. If you’ve ever questioned how policies and the economy affect treatment options and outcomes, or why there is under-representation in healthcare. You will find the answers here.

    Latest >

    • Cancer Therapies That Work But NICE Won’t Fund – What They Mean for Patients.

      How do NICE decisions work? The National Institute for Health and Care excellence serves the primary purpose of health technology assessment (HTA). This is achieved in two ways: by providing clinical guidelines on the most appropriate treatments and care regimes and to provide guidance of whether recommended treatments are cost-effective for commission in the NHS. As…

    • GLP-1 Medications: Side effects, Uncertainty and the Socioeconomic Cost of Rapid Adoption

      GLP-1 receptor agonists have been widely accepted as a phenomena in metabolic health; a “miracle drug”. Originally developed and prescribed for Type 2 Diabetes (T2D), usage has expanded to now cover obesity and weight-related conditions, with the expectation of long-term or lifelong usage. In a relatively short space of time, these medications have entered routine…

    • Episode 1. Neurosurgery

      This week we are in conversation with Dr F, currently working within the Neurosurgery department, in a London hospital. They share their personal anecdotes as a junior doctor within the NHS… “Delayed discharges are common; patients who are medically fit for discharge often remain in hospital due to limited social care post-treatment or surgery”. From…

    • Prevention: The health inequality contributor that needs more attention

      Prevention is the policy we keep ignoring… Modern healthcare systems excel in intervening once people are already unwell – clinicians diagnose, treat, and manage complications whilst we absorb the rise in costs. What these systems are far less structured to do, is prevent the disease from occurring in the first place. An estimated 40% of…

    BTB Insights

    Analytical writing on healthcare systems, economics and policy

    Inside the System

    Conversations with clinicians and practitioners